中文名称：

Nilotinib hydrochloride

中文别名：

尼罗替尼盐酸盐(无水);盐酸尼罗替尼;盐酸尼洛替尼

英文名称：

AMN-107 HCl

英文别名：

Nilotinib hydrochloride anhydrous;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,hydrochloride;Nilotinib hydrochloride monohydrate;Nilotinib hydrochloride;AMN-107 HCl;AKOS027422786;CCG-270077;DTXCID10161459;HY-10159B;Nilotinib HCl;BCP29532;923288-95-3;4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide hydrochloride;Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride (1:1);Nilotinib hydrochloride monohydrate- Bio-X;Nilotinib (as hydrochloride);DA-56184;4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamidehydrochloride;NILOTINIB HYDROCHLORIDE [WHO-DD];4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzamide hydrochloride;Nilotinib HCl;AMN 107; AMN107; AMN-107; Nilotinib hydrochloride anhydrous;4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide hydrochloride;K37N7BYX3X;DTXSID60238968;BN164657;Nilotinib (hydrochloride);CS-0085192;NILOTINIB HYDROCHLORIDE [ORANGE BOOK];AMN 107 hydrochloride;s5205;NILOTINIB HYDROCHLORIDE [VANDF];UNII-K37N7BYX3X;Q27281888;SCHEMBL434496;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrochloride

CAS号：

923288-95-3

分子式：

C₂₈H₂₂F₃N₇O^.HCl

分子量：

565.98

暂无COA证书信息